Literature DB >> 835802

Pseudomembranous colitis associated with cephazolin therapy.

H J Fee, M E Ament, E C Holmes.   

Abstract

This is the first reported case of cephazolin-associated pseudomembranous colitis. The disease followed a relentless course from its onset to twelve days later when the patient underwent total colectomy for multiple perforations and then died of sepsis. Recent reports indicate that the incidence pseudomembranous colitis is higher than initially appreciated. Early recognition of this entity with confirmation by proctosigmoidoscopy and immediate discontinuance of of antibiotic therapy may reduce the morbidity and mortality of this disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835802     DOI: 10.1016/0002-9610(77)90092-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Antibiotic-associated pseudomembranous colitis: pathogenesis and management.

Authors:  M R Keighley
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

2.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

3.  Evaluation of eight cephalosporins in hamster colitis model.

Authors:  J R Ebright; R Fekety; J Silva; K H Wilson
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

4.  Survey of the extrachromosomal gene pool of Clostridium difficile.

Authors:  L L Muldrow; E R Archibold; O L Nunez-Montiel; R J Sheehy
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

5.  Diagnosis of pseudomembranous colitis.

Authors:  A Kappas; N Shinagawa; Y Arabi; H Thompson; D Burdon; F Dimock; R H George; J Alexander-Williams; M R Keighley
Journal:  Br Med J       Date:  1978-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.